Triphenylphosphine-polyethyleneglycol 1000 vitamin E succinate (TPGS 1000-TPP) conjugated compound, and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- PEKING UNIV
- Publication Date
- 2013-03-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a kind of triphenylphosphine-polyethylene glycol 1000 vitamin E succinate (TPGS 1000 -TPP) conjugated compound and its preparation method and application, specifically relating to the application of the conjugated compound in the construction of paclitaxel liposomes. Background technique
[0002] Drug delivery systems modified with functional materials offer a potential strategy for refractory cancers. Tumor refractory is not only related to the pathophysiological state of the patient, but also related to drug delivery. Chemotherapy drugs are usually administered in the form of injection of free drugs, and this method of administration will lead to less accumulation of drugs in tumor lesions and non-targeted distribution of pharmaceuticals in tissues and organs throughout the body.
[0003] In addition, tumor multidrug resistance is the main reason for the failure of chemotherapy, which can lead to drug resistance, re...